M G McMenamin
- Molecular Biology
- Pulmonary and Respiratory Medicine top 10%
- Oncology top 10%
- Cancer Research top 10%
- Immunology
- Topics
- Cancer Research and Treatments (2 papers)Liver physiology and pathology (2 papers)Bioactive Compounds and Antitumor Agents (1 paper)
- Cited by
- Cancer ResearchBiotechnologyOncology
- Journals
- Biochemical JournalBiochemical and Biophysical Research CommunicationsMolecular Pharmacology
- Partner nations
- United StatesGermanyGreece
In The Last Decade
M G McMenamin
10 papers receiving 974 citations
Hit Papers
Peers
Comparison fields: 5 of 99
- Molecular Biology 424
- Pulmonary and Respiratory Medicine 275
- Oncology 255
- Cancer Research 176
- Immunology 138
Countries citing papers authored by M G McMenamin
This map shows the geographic impact of M G McMenamin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M G McMenamin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M G McMenamin more than expected).
Fields of papers citing papers by M G McMenamin
This network shows the impact of papers produced by M G McMenamin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M G McMenamin. The network helps show where M G McMenamin may publish in the future.
Co-authorship network of co-authors of M G McMenamin
This figure shows the co-authorship network connecting the top 25 collaborators of M G McMenamin. A scholar is included among the top collaborators of M G McMenamin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M G McMenamin. M G McMenamin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Mutational analysis of the p63/p73L/p51/p40/CUSP/KET gene in human cancer cell lines using intronic primers. | 107 |
| 2 | 6 | |
| 3 | 31 | |
| 4 | Establishment of a human in vitro mesothelial cell model system for investigating mechanisms of asbestos-induced mesothelioma. | 120 |
| 5 | Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes.breakdown → | 687 |
| 6 | 2 | |
| 7 | Differential metabolism of arachidonic acid in human lung cancer cell lines (HLCCL) | 2 |
| 8 | 4 | |
| 9 | 36 | |
| 10 | Cytochalasin B induces abnormal chromosome segregation in Friend erythroleukaemia cells. | 1 |
| 11 | Chlorozotocin, an anti-tumour agent lacking bone marrow toxicity at therapeutic doses: effects on lymphocyte subpopulations in mice. | 1 |
About M G McMenamin
M G McMenamin is a scholar working on Toxicology, Biochemistry and Hepatology, having authored 11 papers that have together received 997 indexed citations. Recurring topics across this work include Cancer Research and Treatments (2 papers), Liver physiology and pathology (2 papers) and Bioactive Compounds and Antitumor Agents (1 paper). The work is most often cited by research in Cancer Research (176 citations), Biotechnology (89 citations) and Oncology (255 citations). M G McMenamin has collaborated with scholars based in United States, Germany and Greece. Frequent co-authors include Roger R. Reddel, B I Gerwin, J S Rhim, Ke Yan, R. Su, Douglas E. Brash, Caitlin Harris, J.F. Lechner, Curtis C. Harris and Kiyonori Miura. Their work appears in journals such as Biochemical Journal, Biochemical and Biophysical Research Communications and Molecular Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.